ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,996Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 1278

$643K Total Retail Price of All Prescriptions

Rank: 60 out of 1278

1,245 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,245 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 1,245 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 11,829 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
SIMVASTATIN 837 779 1 3
OMEPRAZOLE 578 518 2 6
LEVOTHYROXINE SODIUM 574 553 3 2
LISINOPRIL 477 445 4 1
ATENOLOL 389 378 5 11
AMLODIPINE BESYLATE 312 307 6 5
METOPROLOL TARTRATE 274 247 7 9
WARFARIN SODIUM 267 250 8 17
METFORMIN HCL 252 219 9 4
HYDROCHLOROTHIAZIDE 237 234 10 8
TRIAMTERENE-HCTZ 226 219 11 43
HYDROCODONE-ACETAMINOPHEN 213 187 S3 12 7
FUROSEMIDE 204 192 13 10
ZOLPIDEM TARTRATE 201 186 14 16
ALENDRONATE SODIUM 200 171 15 18
ENALAPRIL MALEATE 193 187 16 58
LOSARTAN POTASSIUM 188 178 17 19
GLIPIZIDE 167 159 18 35
LOVASTATIN 166 166 19 13
GABAPENTIN 157 139 20 12
FLUTICASONE PROPIONATE 156 142 21 24
METOPROLOL SUCCINATE 152 138 22 23
TERAZOSIN HCL 151 149 23 59
POTASSIUM CHLORIDE 150 144 24 21
PANTOPRAZOLE SODIUM 144 131 25 34
ATORVASTATIN CALCIUM 144 141 25 15
TRAMADOL HCL 132 119 27 25
TRAMADOL HCL-ACETAMINOPHEN 129 125 28 221
PRAVASTATIN SODIUM 120 110 29 14
RANITIDINE HCL 117 102 30 20
FLUOXETINE HCL 115 93 31 41
AZITHROMYCIN 115 97 31 37
LIPITOR 115 108 31 95
CLOPIDOGREL 113 105 34 45
SERTRALINE HCL 111 95 35 28
TAMSULOSIN HCL 103 97 36 32
PROAIR HFA 96 88 37 26
PLAVIX 89 82 38 64
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 86 39 30
CIPROFLOXACIN HCL 84 77 40 53
METHYLPREDNISOLONE 84 70 40 93
LANTUS 77 70 42 33
GLIPIZIDE XL 77 67 42 101
PAROXETINE HCL 72 63 44 56
DOXYCYCLINE HYCLATE 70 46 45 123
CITALOPRAM HBR 70 54 45 22
DILTIAZEM ER 66 62 47 103
ALLOPURINOL 65 64 48 36
JANUVIA 64 64 49 68
INSULIN SYRINGE 62 57 50 50
DIOVAN 61 53 51 44
CLONIDINE HCL 58 58 52 60
DICLOFENAC SODIUM 58 49 52 74
DIGOXIN 57 46 54 79
ISOSORBIDE MONONITRATE ER 57 52 54 96
GEMFIBROZIL 56 52 56 54
OXYBUTYNIN CHLORIDE 55 52 57 80
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 58 75
FINASTERIDE 51 46 59 82
VERAPAMIL ER 50 47 60 84
CARVEDILOL 50 49 60 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.